BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11554000)

  • 1. Psychiatric complications in the treatment of Parkinson's disease.
    Wolters EC
    Adv Neurol; 2001; 86():385-93. PubMed ID: 11554000
    [No Abstract]   [Full Text] [Related]  

  • 2. Punding in Parkinson's disease.
    O'Sullivan SS; Evans AH; Lees AJ
    Pract Neurol; 2007 Nov; 7(6):397-9. PubMed ID: 18024780
    [No Abstract]   [Full Text] [Related]  

  • 3. [Psychiatric complications of Parkinson's disease: their symptoms and treatment].
    Castro-García A; Sesar-Ignacio A; Ares-Pensado B
    Rev Neurol; 2004 Oct 1-15; 39(7):646-50. PubMed ID: 15490352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behavioral disorders in Parkinson's disease: from pathophysiology to the mastery of dopaminergic treatment].
    Thobois S; Ardouin C; Schmitt E; Lhommée E; Klinger H; Xie J; Lagrange C; Kistner A; Aya Kombo M; Fleury V; Poisson A; Fraix V; Broussolle E; Pollak P; Krack P
    Rev Neurol (Paris); 2010 Oct; 166(10):816-21. PubMed ID: 20739041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive, affective, and psychiatric features of Parkinson's disease.
    Barbas NR
    Clin Geriatr Med; 2006 Nov; 22(4):773-96, v-vi. PubMed ID: 17000335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten most commonly asked questions about the psychiatric aspects of Parkinson's disease.
    Reich SG; Marsh L
    Neurologist; 2003 Jan; 9(1):50-6. PubMed ID: 12801432
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs to treat dementia and psychosis: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S120-7. PubMed ID: 12211152
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of the behavioral aspects of Parkinson's disease.
    Borek LL; Chou KL; Friedman JH
    Expert Rev Neurother; 2007 Jun; 7(6):711-25. PubMed ID: 17563253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease is a neuropsychiatric disorder.
    Agid Y; Arnulf I; Bejjani P; Bloch F; Bonnet AM; Damier P; Dubois B; François C; Houeto JL; Iacono D; Karachi C; Mesnage V; Messouak O; Vidailhet M; Welter ML; Yelnik J
    Adv Neurol; 2003; 91():365-70. PubMed ID: 12442695
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequency of psychiatric disorders in young-onset Parkinson's disease does not differ from typical-onset Parkinson's disease.
    Kummer A; Cardoso F; Teixeira AL
    Parkinsonism Relat Disord; 2009 Feb; 15(2):153-5. PubMed ID: 18514013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease--Part 3: Neuropsychiatric symptoms.
    Weintraub D; Comella CL; Horn S
    Am J Manag Care; 2008 Mar; 14(2 Suppl):S59-69. PubMed ID: 18402509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intervening in the neuropsychiatric features of Parkinson's disease.
    Weintraub D; Stern MB
    Expert Rev Neurother; 2007 Jun; 7(6):699-710. PubMed ID: 17563252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavioral disorders in Parkinson's disease. Genetic, pharmacological and medico-legal aspects].
    Sobrido MJ; Dias-Silva JJ; Quintáns B
    Rev Neurol; 2009 Jan; 48 Suppl 1():S43-8. PubMed ID: 19222015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychiatric symptoms of Parkinson's disease--an overview from the studies on dopaminergic nerves].
    Ishida Y
    Seishin Shinkeigaku Zasshi; 2005; 107(3):290-3. PubMed ID: 15856754
    [No Abstract]   [Full Text] [Related]  

  • 15. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of behavioural symptoms and dementia in Parkinson's disease.
    Hanagasi HA; Emre M
    Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for non-motor symptoms in late-stage Parkinson's disease.
    Coelho M; Ferreira J; Rosa M; Sampaio C
    Expert Opin Pharmacother; 2008 Mar; 9(4):523-35. PubMed ID: 18312155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preface to special issue on Mental Dysfunction in Parkinson's Disease.
    Reichmann H; Korczyn AD
    J Neurol Sci; 2010 Feb; 289(1-2):1. PubMed ID: 19896143
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychiatric disorders in Parkinson's disease.
    Gannon M; Murphy D
    Br J Hosp Med; 1992 May 6-19; 47(9):663-6. PubMed ID: 1617338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.